173.25
price up icon2.47%   4.17
pre-market  プレマーケット:  173.00   -0.25   -0.14%
loading
前日終値:
$169.08
開ける:
$170.1
24時間の取引高:
2.00M
Relative Volume:
1.17
時価総額:
$23.25B
収益:
$1.08B
当期純損益:
$-433.19M
株価収益率:
-50.95
EPS:
-3.4004
ネットキャッシュフロー:
$-225.09M
1週間 パフォーマンス:
+6.56%
1か月 パフォーマンス:
-2.26%
6か月 パフォーマンス:
+95.76%
1年 パフォーマンス:
+144.53%
1日の値動き範囲:
Value
$0.00
$0.00
1週間の範囲:
Value
$158.68
$175.08
52週間の値動き範囲:
Value
$68.02
$191.05

Guardant Health Inc Stock (GH) Company Profile

Name
名前
Guardant Health Inc
Name
セクター
Healthcare (1053)
Name
電話
855-698-8887
Name
住所
3100 HANOVER STREET, PALO ALTO
Name
職員
2,506
Name
Twitter
@guardanthealth
Name
次回の収益日
2026-11-05
Name
最新のSEC提出書
Name
GH's Discussions on Twitter

Compare GH vs TMO, DHR, NTRA, A, IQV

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
GH icon
GH
Guardant Health Inc
173.25 23.25B 1.08B -433.19M -225.09M -3.4004
TMO icon
TMO
Thermo Fisher Scientific Inc
684.89 253.24B 45.20B 6.87B 6.75B 18.19
DHR icon
DHR
Danaher Corp
232.97 163.77B 24.78B 3.68B 5.29B 5.1743
NTRA icon
NTRA
Natera Inc
404.90 58.36B 2.50B -226.32M 71.51M -1.6412
A icon
A
Agilent Technologies Inc
175.96 49.61B 7.23B 1.41B 1.09B 4.979
IQV icon
IQV
Iqvia Holdings Inc
273.60 45.03B 16.63B 1.39B 2.12B 8.0674

Guardant Health Inc Stock (GH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-10-23 開始されました Roth Capital Buy
2026-09-09 再開されました UBS Buy
2026-09-08 開始されました Rothschild & Co Redburn Buy
2026-06-26 再開されました Bernstein Outperform
2026-06-12 開始されました RBC Capital Mkts Outperform
2026-06-05 開始されました Goldman Buy
2026-06-02 アップグレード Evercore ISI In-line → Outperform
2026-06-02 再開されました Wolfe Research Outperform
2026-02-20 繰り返されました Canaccord Genuity Buy
2026-02-17 開始されました Robert W. Baird Outperform
2026-01-05 ダウングレード Evercore ISI Outperform → In-line
2025-12-02 再開されました Morgan Stanley Overweight
2025-09-25 アップグレード Wolfe Research Peer Perform → Outperform
2025-09-22 再開されました Wells Fargo Overweight
2025-04-10 開始されました Mizuho Outperform
2025-01-23 開始されました Barclays Overweight
2024-06-28 アップグレード Guggenheim Neutral → Buy
2024-06-03 再開されました Jefferies Buy
2024-04-24 再開されました Craig Hallum Buy
2023-12-14 開始されました Guggenheim Neutral
2023-12-13 開始されました Wolfe Research Peer Perform
2023-11-13 アップグレード Raymond James Mkt Perform → Outperform
2023-09-28 開始されました Bernstein Outperform
2023-09-27 アップグレード Piper Sandler Neutral → Overweight
2023-07-05 再開されました JP Morgan Overweight
2023-05-26 アップグレード Citigroup Neutral → Buy
2023-05-05 開始されました UBS Buy
2023-03-09 ダウングレード Citigroup Buy → Neutral
2023-01-05 開始されました Scotiabank Sector Outperform
2022-11-01 ダウングレード Piper Sandler Overweight → Neutral
2022-10-19 開始されました Craig Hallum Buy
2022-10-06 開始されました Stephens Overweight
2022-08-25 開始されました Credit Suisse Outperform
2022-06-03 開始されました Piper Sandler Overweight
2022-04-28 再開されました BTIG Research Buy
2022-02-24 繰り返されました Canaccord Genuity Buy
2022-02-24 繰り返されました Citigroup Buy
2022-02-24 繰り返されました Cowen Outperform
2022-02-24 繰り返されました Morgan Stanley Overweight
2022-02-24 繰り返されました SVB Leerink Outperform
2022-02-24 繰り返されました Stifel Buy
2022-02-24 繰り返されました Wells Fargo Overweight
2021-10-15 再開されました Cowen Outperform
2021-06-15 開始されました Raymond James Mkt Perform
2021-06-03 開始されました Goldman Buy
2021-05-25 開始されました Wells Fargo Overweight
2021-01-11 開始されました Stifel Buy
2020-09-09 開始されました Morgan Stanley Overweight
2020-06-12 開始されました BTIG Research Buy
2020-02-21 開始されました Guggenheim Buy
2020-01-07 開始されました Citigroup Buy
2019-08-07 繰り返されました Canaccord Genuity Buy
2019-04-16 開始されました Canaccord Genuity Buy
2019-04-10 アップグレード BofA/Merrill Neutral → Buy
2019-02-28 繰り返されました BofA/Merrill Neutral
2018-10-29 開始されました BofA/Merrill Neutral
2018-10-29 開始されました JP Morgan Overweight
2018-10-29 開始されました William Blair Outperform
すべてを表示

Guardant Health Inc (GH) 最新ニュース

pulisher
Oct 22, 2026

Form 4 Guardant Health Inc: Roberto Mignone (Director) For: 21 October - Investing.com Nigeria

Oct 22, 2026
pulisher
Oct 21, 2026

Natera Partners With TransCode to Advance Colorectal Cancer Trial - Zacks Investment Research

Oct 21, 2026
pulisher
Oct 20, 2026

Guardant Health director Tariq Musa sells $19,242 in stock By Investing.com - Investing.com South Africa

Oct 20, 2026
pulisher
Oct 19, 2026

Form 4 Guardant Health Inc: Medina Manuel Hidalgo (Director) For: 17 October - Investing.com Nigeria

Oct 19, 2026
pulisher
Oct 19, 2026

Form 4 Guardant Health Inc: Medina Manuel Hidalgo (Director) For: 17 October - Investing.com Canada

Oct 19, 2026
pulisher
Oct 19, 2026

Guardant Health director Tariq Musa sells $19,242 in stock - Investing.com

Oct 19, 2026
pulisher
Oct 19, 2026

Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)? - Zacks Investment Research

Oct 19, 2026
pulisher
Oct 16, 2026

Director Tariq Musa proposes selling 116 Guardant Health (GH) shares. - Stock Titan

Oct 16, 2026
pulisher
Oct 16, 2026

Guardant Health director Alex M. Azar II sells $11,032 in stock By Investing.com - Investing.com South Africa

Oct 16, 2026
pulisher
Oct 16, 2026

Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 14 October By Investing.com - Investing.com South Africa

Oct 16, 2026
pulisher
Oct 15, 2026

Guardant Health director Alex M. Azar II sells $11,032 in stock - Investing.com

Oct 15, 2026
pulisher
Oct 15, 2026

Guardant Health director Alex M. Azar II sells $11,032 in stock - Investing.com Canada

Oct 15, 2026
pulisher
Oct 15, 2026

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar - Zacks Investment Research

Oct 15, 2026
pulisher
Oct 14, 2026

A director proposes selling 69 Guardant Health (GH) shares valued at $11,032. - Stock Titan

Oct 14, 2026
pulisher
Oct 14, 2026

Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 12 October - Investing.com Canada

Oct 14, 2026
pulisher
Oct 14, 2026

Form 4 Guardant Health Inc: Alex M. Azar II (Director) For: 12 October - Investing.com Nigeria

Oct 14, 2026
pulisher
Oct 13, 2026

Form 4 Guardant Health Inc: Helmy Eltoukhy (Director, Co-Chief Executive Officer) For: 30 September - Investing.com Canada

Oct 13, 2026
pulisher
Oct 13, 2026

Form 4 Guardant Health Inc: Helmy Eltoukhy (Director, Co-Chief Executive Officer) For: 30 September - Investing.com Nigeria

Oct 13, 2026
pulisher
Oct 11, 2026

Julia Letlow Stock Trades and Disclosures - TechGraph

Oct 11, 2026
pulisher
Sep 22, 2026

Form 4 Guardant Health Inc For: 22 September By Investing.com - Investing.com Canada

Sep 22, 2026
pulisher
Sep 22, 2026

Form 4 Guardant Health Inc For: 22 September By Investing.com - Investing.com Nigeria

Sep 22, 2026
pulisher
Sep 22, 2026

Form 4 Guardant Health Inc For: 22 September By Investing.com - Investing.com UK

Sep 22, 2026
pulisher
Sep 17, 2026

Director Steve Krognes Sells 6,674 Shares of Guardant Health Inc (GH) - GuruFocus

Sep 17, 2026
pulisher
Sep 16, 2026

Guardant Health (GH) director plans new stock sale - Stock Titan

Sep 16, 2026
pulisher
Sep 16, 2026

Guardant Health (NASDAQ: GH) director may sell $144K in equity-comp stock - Stock Titan

Sep 16, 2026
pulisher
Sep 16, 2026

Guardant Health (NASDAQ: GH) director moves to sell 6,674 shares - Stock Titan

Sep 16, 2026
pulisher
Sep 15, 2026

Officer at Guardant Health (NASDAQ: GH) plans sale of 7,738 shares under Rule 144 - Stock Titan

Sep 15, 2026
pulisher
Sep 14, 2026

Guardant Health CIO Kumud Kalia sells $632k in stock - Investing.com

Sep 14, 2026
pulisher
Sep 13, 2026

Guardant Health Inc Share PriceGH, RNS News, Articles, Quotes, & Charts - Proactive financial news

Sep 13, 2026
pulisher
Sep 11, 2026

Guardant Health (NASDAQ: GH) officer moves to sell more stock - Stock Titan

Sep 11, 2026
pulisher
Sep 11, 2026

(GH) Volatility Zones as Tactical Triggers - Stock Traders Daily

Sep 11, 2026
pulisher
Sep 10, 2026

Bernstein reiterates Guardant Health stock rating on margin outlook - Investing.com

Sep 10, 2026
pulisher
Sep 10, 2026

Bernstein reiterates Guardant Health stock rating on margin outlook By Investing.com - Investing.com Canada

Sep 10, 2026
pulisher
Sep 09, 2026

Guardant Health and Collaborators to Present 20 Abstracts Highlighting Portfolio of Liquid Biopsy Tests for Early Detection and Ongoing Treatment Management at 2026 World Conference on Lung Cancer - BioSpace

Sep 09, 2026
pulisher
Sep 09, 2026

GH Maintained by UBS -- Price Target Raised to $225 - GuruFocus

Sep 09, 2026
pulisher
Sep 09, 2026

Guardant Health and Collaborators Present 20 Abstracts Showcasing Advances in Liquid Biopsy Tests and Methylation-Based Tumor Classification for Lung Cancer At 2026 World Conference on Lung Cancer - marketscreener.com

Sep 09, 2026
pulisher
Sep 08, 2026

GH Initiates Coverage On Guardant Health -- Buy Rating by Rothsc - GuruFocus

Sep 08, 2026
pulisher
Sep 08, 2026

Business Insider Names Guardant Health One of America's Most Innovative Businesses - Business Wire

Sep 08, 2026
pulisher
Sep 08, 2026

GH Initiates Coverage On Guardant Health -- Buy Rating by Rothsc - GuruFocus

Sep 08, 2026
pulisher
Sep 08, 2026

What Makes Guardant Health (GH) a Compelling Bet? - Yahoo Finance

Sep 08, 2026
pulisher
Sep 08, 2026

Rothschild Redburn initiates Guardant Health stock with buy rating By Investing.com - Investing.com Canada

Sep 08, 2026
pulisher
Sep 08, 2026

Rothschild Redburn initiates Guardant Health stock with buy rating By Investing.com - Investing.com India

Sep 08, 2026
pulisher
Sep 08, 2026

Rothschild Redburn initiates Guardant Health stock with buy rating - investing.com

Sep 08, 2026
pulisher
Sep 08, 2026

Rothschild Redburn initiates Guardant Health stock with buy rating - Investing.com

Sep 08, 2026
pulisher
Sep 07, 2026

AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah - Zacks Investment Research

Sep 07, 2026
pulisher
Sep 07, 2026

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 20% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews

Sep 07, 2026
pulisher
Sep 06, 2026

Guardant Health Leads the Way in Blood-Based Single Cancer Screening - Morningstar

Sep 06, 2026
pulisher
Sep 05, 2026

Guardant Health Stock Price Forecast. Should You Buy GH? - StockInvest.us

Sep 05, 2026
pulisher
Sep 05, 2026

GH Looks 144.6% Overvalued on GF Value™ - GuruFocus

Sep 05, 2026
pulisher
Sep 04, 2026

Guardant Health Faces a $245 Million Patent Judgment, But Its Newer Tests Could Offer Protection - Yahoo Finance

Sep 04, 2026

Guardant Health Inc (GH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Guardant Health Inc (GH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Hidalgo Medina Manuel
Director
Oct 17 '26
Option Exercise
0.00
232
0
5,252
Tariq Musa
Director
Oct 16 '26
Proposed Sale
165.88
116
19,242
0
Tariq Musa
Director
Oct 16 '26
Sale
165.88
116
19,242
11,583
Tariq Musa
Director
Oct 15 '26
Option Exercise
0.00
250
0
11,699
Azar Alex M II
Director
Oct 14 '26
Proposed Sale
159.88
69
11,032
0
Azar Alex M II
Director
Oct 14 '26
Sale
159.89
69
11,032
893
Azar Alex M II
Director
Oct 12 '26
Option Exercise
0.00
137
0
962
Kalia Kumud
Chief Information Officer
Oct 01 '26
Option Exercise
0.00
6,046
0
45,840
Monroe Terilyn J.
Chief People Officer
Oct 01 '26
Option Exercise
0.00
4,019
0
26,998
Saia John G.
Chief Legal Officer
Oct 01 '26
Option Exercise
0.00
7,063
0
46,054
LH LH
$329.90
price up icon 0.29%
DGX DGX
$242.95
price up icon 0.44%
$676.77
price up icon 1.13%
$160.39
price up icon 1.02%
CRL CRL
$357.27
price up icon 3.45%
$183.78
price down icon 0.80%
大文字化:     |  ボリューム (24 時間):